BFS
PTCT icon

Bare Financial Services’s PTC Therapeutics PTCT Stock Holding History

Bare Financial Services’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24K Buy
294
+115
+64% +$8.3K 0.01% 207
2026
Q1 		$12.2K Buy
179
+158
+752% +$11.2K ﹤0.01% 262
2025
Q4 		$1.59K Buy
21
+17
+425% +$1.24K ﹤0.01% 944
2025
Q3 		$245 Sell
4
-17
-81% -$885 ﹤0.01% 1385
2025
Q2 		$1.03K Buy
+21
New +$997 ﹤0.01% 919

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Bare Financial Services's PTCT Position: Q2 2026 in Review

Bare Financial Services increased its PTC Therapeutics (PTCT) stake by 64% in Q2 2026, buying an estimated $8.3K and bringing the position to 294 shares worth $24K. The position accounts for 0.01% of the portfolio, ranked #207.

Bare Financial Services first reported a position in PTCT in Q2 2025 and has held it in 5 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Bare Financial Services held 294 shares of PTC Therapeutics worth $24K as of Q2 2026.
  • Bare Financial Services bought 115 PTC Therapeutics shares in Q2 2026, an estimated $8.3K.
  • PTC Therapeutics made up 0.01% of Bare Financial Services's portfolio in Q2 2026, its #207 holding.
  • Bare Financial Services first reported a position in PTC Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Bare Financial Services's 13F filing for Q2 2026, filed 27 Jul 2026.